- Sanofi - Orexigen Therapeutics - Amgen - Johnson & Johnson - Abbott Laboratories - Takeda Pharmaceutical Company - Zafgen - Currax Pharmaceuticals - Rhythm Pharmaceuticals Key Developments In September 2025, Eli Lilly announced plans to launch its experimental weight-loss pill, orforglipron, in India
Fat dissolving works well on a defined double chin that has resisted diet and exercise, and much less well as a weight-management tool
Collagen fiber alignment is a determinant of tendon mechanical strength, and BPC-157-treated tendons in rat studies show more parallel, organized fiber arrangement compared to the disorganized scar tissue in untreated injuries
TB-500 contributes to wound healing and muscle recovery, while BPC-157 accelerates tissue repair and vascular support
Approved Uses and Current Clinical Evidence in the UK Neither cagrilintide nor retatrutide is licensed by the MHRA or EMA
More: Serena Williams, the Ozempic craze and what it says about body image A couple of clinical trials show muscle loss can be prevented when GLP-1s are paired with substances such as Selective Androgen Receptor Modulators (SARMs), according to Fedoruk
